Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.24), $0.02 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $38.4 million versus the consensus estimate of $40.38 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.